Total Payments
$8,350
2024 Payments
$2,538
Companies
49
Transactions
314
Medicare Patients
859
Medicare Billing
$60,856
Payment Breakdown by Category
Food & Beverage$8,048 (96.4%)
Education$302.52 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,048 | 310 | 96.4% |
| Education | $302.52 | 4 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $911.66 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $895.07 | 28 | $0 (2024) |
| Novo Nordisk Inc | $711.18 | 37 | $0 (2024) |
| Amgen Inc. | $466.80 | 21 | $0 (2024) |
| Abbott Laboratories | $443.67 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $366.22 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $314.82 | 4 | $0 (2023) |
| PFIZER INC. | $279.42 | 14 | $0 (2024) |
| Antares Pharma, Inc. | $264.91 | 14 | $0 (2024) |
| ANI Pharmaceuticals, Inc. | $261.55 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,538 | 96 | AstraZeneca Pharmaceuticals LP ($364.26) |
| 2023 | $2,788 | 94 | ABBVIE INC. ($591.99) |
| 2022 | $673.28 | 28 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($134.75) |
| 2021 | $2,351 | 96 | Abbott Laboratories ($277.06) |
All Payment Transactions
314 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: VACCINES | ||||||
| 12/04/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $33.94 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $15.92 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Diabetes Care | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Cardio-renal | ||||||
| 10/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/16/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.63 | General |
| 10/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/07/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Obesity | ||||||
| 10/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 492 | 544 | $64,701 | $31,667 |
| 2022 | 7 | 367 | 448 | $51,867 | $29,188 |
Total Patients
859
Total Services
992
Medicare Billing
$60,856
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 91 | $16,350 | $8,196 | 50.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 66 | 66 | $13,150 | $5,800 | 44.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $8,909 | $4,447 | 49.9% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 24 | 24 | $3,600 | $3,355 | 93.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 47 | $7,050 | $3,272 | 46.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 38 | 39 | $2,002 | $1,961 | 98.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 44 | 44 | $7,200 | $1,523 | 21.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 45 | 88 | $2,640 | $1,412 | 53.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 14 | 14 | $700.00 | $567.70 | 81.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 21 | 21 | $580.00 | $340.20 | 58.7% |
| 87807 | Detection test by immunoassay with direct visual observation for respiratory syncytial virus | Office | 2023 | 25 | 25 | $750.00 | $321.00 | 42.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 12 | $900.00 | $269.92 | 30.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 15 | $210.00 | $128.71 | 61.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 22 | 22 | $660.00 | $75.02 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 100 | $17,970 | $10,655 | 59.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 93 | 135 | $6,907 | $6,796 | 98.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 34 | $5,100 | $2,895 | 56.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $4,870 | $2,891 | 59.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $6,200 | $2,858 | 46.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 54 | 54 | $8,600 | $1,886 | 21.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 37 | 74 | $2,220 | $1,208 | 54.4% |
About Aman Sharma
Aman Sharma is a Family healthcare provider based in Yonkers, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2020. The National Provider Identifier (NPI) number assigned to this provider is 1992304349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Aman Sharma has received a total of $8,350 in payments from pharmaceutical and medical device companies, with $2,538 received in 2024. These payments were reported across 314 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($8,048).
As a Medicare-enrolled provider, Sharma has provided services to 859 Medicare beneficiaries, totaling 992 services with total Medicare billing of $60,856. Data is available for 2 years (2022–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Yonkers, NY
- Active Since 10/17/2020
- Last Updated 05/20/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1992304349
Products in Payments
- VRAYLAR (Drug) $588.08
- BREZTRI (Drug) $548.38
- TRELEGY ELLIPTA (Drug) $366.22
- Otezla (Drug) $330.15
- Ozempic (Drug) $296.31
- FreeStyle Libre Pro (Device) $277.06
- PURIFIED CORTROPHIN GEL (Drug) $261.55
- XYOSTED (Drug) $231.18
- ZENPEP (Drug) $224.13
- FARXIGA (Drug) $219.73
- QUVIVIQ (Drug) $206.75
- UBRELVY (Drug) $195.45
- Rybelsus (Drug) $186.01
- XARELTO (Drug) $184.75
- Kerendia (Drug) $178.20
- INJECTAFER (Drug) $172.66
- Vascepa (Drug) $166.69
- Dayvigo (Drug) $153.02
- CAPLYTA (Drug) $148.94
- Cologuard Collection Kit (Device) $147.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Yonkers
Mrs. Shanelly Singh, Fnp-Bc, FNP-BC
Family — Payments: $10,618
Family $10,618
Mrs. Susan Daly, Fnp, FNP
Family — Payments: $5,227
Family $5,227
Mrs. Evelyn Batres, Fnp, FNP
Family — Payments: $4,381
Family $4,381
Mr. Robert Donaldson, Np, NP
Family — Payments: $2,590
Family $2,590
Alexis Devens
Family — Payments: $2,586
Family $2,586
Mrs. Cigi Mathew, Np, NP
Family — Payments: $2,397
Family $2,397